儿童激素依赖频复发型肾病综合征的研究进展及展望
Research Progress and Prospects of Steroid-Dependent and Frequent Relapsing, Nephrotic Syndrome in Children
DOI: 10.12677/acm.2024.1461848, PDF,   
作者: 胡仁洁, 陈 汉：重庆医科大学附属儿童医院肾脏内科，国家儿童健康与疾病临床医学研究中心，儿童发育疾病研究教育部重点实验室，儿科学重庆市重点实验室，重庆
关键词: 原发性肾病综合征；免疫功能紊乱；激素依赖；频复发；免疫治疗；Primary Nephrotic Syndrome； Immune System Disorder； Steroid-Dependent； Frequent Relapse； Immunosuppressive Therapy
摘要: 激素依赖及频复发肾病(steroid-dependent/frequent relapsing nephrotic syndrome, SDNS/FRNS)是儿童原发性肾病综合征(primary nephrotic syndrome, PNS)的重要激素应答类型。SDNS/FRNS患者主要表现为激素依赖及频繁复发，其治疗过程棘手，部分患者甚至进展为终末期肾病，对患者家庭及社会构成负担，其机制仍不清楚，既往研究大多聚焦复杂免疫分子网络协同参与SDNS/FRNS发生、发展。近年来，随着多组学技术开展，对SDNS/FRNS疾病有了新的认识。本文从SDNS/FRNS的临床表现、发病机制(T细胞免疫紊乱、B细胞免疫功能紊乱、调节性T细胞异常及足细胞异常)、最新治疗方案等几个重要环节进行综述，为儿童临床PNS肾脏疾病管理提供新的策略。
Abstract: Steroid-dependent and frequent relapsing nephrotic syndrome is an important type of response to steroid in primary nephrotic syndrome (PNS) in children. SDNS/FRNS patients develop frequently relapsing or steroid-dependent forms, and the treatment is difficult, some patients even progress to ESRD, which increases the burden of patient’s family and social burden. The pathogenesis of PNS is as yet unknown, most previous studies have focused on complex immune modulation to participate in the occurrence and development of SDNS/FRNS. In recent years, with the development of multi-omics profiling, there has been a new understanding of SDNS/FRNS. In this review, we shed light on clinical manifestations, its pathogenesis (T-cell dysregulation, B-cell dysfunction, circulating regulatory Tcells (Tregs), abnormalities functional alterations of podocytes), and recently treatment protocols, advances in our understanding of the pathogenesis of PNS may help drive new approaches.
文章引用：胡仁洁, 陈汉. 儿童激素依赖频复发型肾病综合征的研究进展及展望[J]. 临床医学进展, 2024, 14(6): 824-832. https://doi.org/10.12677/acm.2024.1461848

参考文献

[1] Noone, D.G., Iijima, K. and Parekh, R. (2018) Idiopathic Nephrotic Syndrome in Children. The Lancet, 392, 61-74. [Google Scholar] [CrossRef] [PubMed]
[2] 杨帆, 蒋小云. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016)解读[J]. 中华儿科杂志, 2017, 55(10): 738-742.
[3] 中华医学会儿科学分会肾脏学组. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016) [J]. 中华儿科杂志, 2017, 55(10): 729-734.
[4] Rovin, B.H., Adler, S.G., Barratt, J., Bridoux, F., Burdge, K.A., Chan, T.M., et al. (2021) Executive Summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney International, 100, 753-779. [Google Scholar] [CrossRef] [PubMed]
[5] Dowerah, P., Gogoi, A., Shira, C.D., et al. (2023) A Study of Dyslipidemia and Its Clinical Implications in Childhood Nephrotic Syndrome. Cureus, 15, e47434. [Google Scholar] [CrossRef] [PubMed]
[6] Shatat, I.F., Becton, L.J. and Woroniecki, R.P. (2019) Hypertension in Childhood Nephrotic Syndrome. Frontiers in Pediatrics, 7, Article 287. [Google Scholar] [CrossRef] [PubMed]
[7] Sarkar, S., Sinha, A., Lakshmy, R., Agarwala, A., Saxena, A., Hari, P., et al. (2016) Ambulatory Blood Pressure Monitoring in Frequently Relapsing Nephrotic Syndrome. The Indian Journal of Pediatrics, 84, 31-35. [Google Scholar] [CrossRef] [PubMed]
[8] 罗百文, 邓新强, 温东辉, 等. 儿童原发性肾病综合征血清免疫球蛋白水平的变化分析[J]. 中国医学工程, 2020, 28(1): 56-58.
[9] 温晓莹, 曾维嘉, 林晓红, 等. 儿童频复发与非频复发型原发单纯型肾病综合征感染特点比较[J]. 现代医院, 2017, 17(7): 1007-1010.
[10] Takao, H., Nishi, K., Funaki, T., et al. (2023) Changes in Patterns of Infection Associated with Pediatric Idiopathic Nephrotic Syndrome: A Single-Center Experience in Japan. The Journal of Pediatrics, 254, 11-16. [Google Scholar] [CrossRef] [PubMed]
[11] Guernsey, D., Arun, A., Agha, R. and Kupferman, J.C. (2022) Streptococcus Pneumoniae Meningitis in a Child with Idiopathic Nephrotic Syndrome: A Case Report. Journal of Medical Case Reports, 16, Article No. 403. [Google Scholar] [CrossRef] [PubMed]
[12] Inaba, Y., Miyazono, A., Imadome, K., et al. (2023) A Successful Treatment for Chronic Active Epstein-Barr Virus Disease with Nephrotic Syndrome. CEN Case Reports, 13, 145-148. [Google Scholar] [CrossRef] [PubMed]
[13] Fang, W., Hong, N., Li, Y., et al. (2017) Cryptococcosis in Patients with Nephrotic Syndrome: A Pooled Analysis of Cases. Mycopathologia, 182, 517-525. [Google Scholar] [CrossRef] [PubMed]
[14] Szymanik-Grzelak, H., Kuźma-Mroczkowska, E., Skrzypczyk, P., Bielecka, T., Kotula, I. and Pańczyk-Tomaszewska, M. (2017) Tuberculosis Infection in Children with Proteinuria/Nephrotic Syndrome. Central European Journal of Immunology, 3, 318-323. [Google Scholar] [CrossRef] [PubMed]
[15] 邢二庆, 王成祥, 尚家星, 等. 儿童肾病综合征并发侵袭性真菌感染危险因素及血清PCT和CRP水平[J]. 中华医院感染学杂志, 2021, 31(13): 1987-1991.
[16] Ishikura, K., Matsumoto, S., Sako, M., Tsuruga, K., Nakanishi, K., Kamei, K., et al. (2015) Clinical Practice Guideline for Pediatric Idiopathic Nephrotic Syndrome 2013: Medical Therapy. Clinical and Experimental Nephrology, 19, 6-33. [Google Scholar] [CrossRef] [PubMed]
[17] Iijima, K., Sako, M., Oba, M., Tanaka, S., Hamada, R., Sakai, T., et al. (2022) Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome. Journal of the American Society of Nephrology, 33, 401-419. [Google Scholar] [CrossRef] [PubMed]
[18] Audard, V., Larousserie, F., Grimbert, P., Abtahi, M., Sotto, J., Delmer, A., et al. (2006) Minimal Change Nephrotic Syndrome and Classical Hodgkin’s Lymphoma: Report of 21 Cases and Review of the Literature. Kidney International, 69, 2251-2260. [Google Scholar] [CrossRef] [PubMed]
[19] Shalhoub, R. (1974) Pathogenesis of Lipoid Nephrosis: A Disorder of T-Cell Function. The Lancet, 304, 556-560. [Google Scholar] [CrossRef] [PubMed]
[20] Kanai, T., Shiraishi, H., Yamagata, T., Ito, T., Odaka, J., Saito, T., et al. (2010) Th2 Cells Predominate in Idiopathic Steroid-Sensitive Nephrotic Syndrome. Clinical and Experimental Nephrology, 14, 578-583. [Google Scholar] [CrossRef] [PubMed]
[21] 张嘉琦, 吴玉秀, 张倩, 等. 儿童激素敏感型肾病综合征频复发因素分析[J]. 中国妇幼健康研究, 2023, 34(5): 73-81.
[22] Bhatia, D., Sinha, A., Hari, P., Sopory, S., Saini, S., Puraswani, M., et al. (2018) Rituximab Modulates T-and B-Lymphocyte Subsets and Urinary CD80 Excretion in Patients with Steroid-Dependent Nephrotic Syndrome. Pediatric Research, 84, 520-526. [Google Scholar] [CrossRef] [PubMed]
[23] Shimada, M., Ishimoto, T., Lee, P.Y., Lanaspa, M.A., Rivard, C.J., Roncal-Jimenez, C.A., et al. (2011) Toll-Like Receptor 3 Ligands Induce CD80 Expression in Human Podocytes via an NF-B-Dependent Pathway. Nephrology Dialysis Transplantation, 27, 81-89. [Google Scholar] [CrossRef] [PubMed]
[24] Colucci, M., Carsetti, R., Serafinelli, J., et al. (2019) Prolonged Impairment of Immunological Memory after Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome. Frontiers in Immunology, 10, Article 1653. [Google Scholar] [CrossRef] [PubMed]
[25] 于跑, 彭倩倩, 董晨, 等. B淋巴细胞表型在激素依赖及频繁复发肾病综合征患儿的临床意义[J]. 实用医学杂志, 2020, 36(7): 954-958.
[26] Kim, Y., Ryu, J., Ryu, M.S., Lim, S., Han, K.O., Lim, I.K., et al. (2014) C-Reactive Protein Induces G2/M Phase Cell Cycle Arrest and Apoptosis in Monocytes through the Upregulation of B-Cell Translocation Gene 2 Expression. FEBS Letters, 588, 625-631. [Google Scholar] [CrossRef] [PubMed]
[27] Yildiz, B., Cetin, N., Kural, N., et al. (2013) CD19+ CD23+ B Cells, CD4+ CD25+ T Cells, E-Selectin and Interleukin-12 Levels in Children with Steroid Sensitive Nephrotic Syndrome. Italian Journal of Pediatrics, 39, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[28] Mohamed El Mashad, G., Abd El Hady Ibrahim, S. and Abd Allah Abdelnaby, S. (2017) Immunoglobulin G and M Levels in Childhood Nephrotic Syndrome: Two Centers Egyptian Study. Electronic Physician, 9, 3728-3732. [Google Scholar] [CrossRef] [PubMed]
[29] 王汝琼, 林道炯, 吴守业, 等. 利妥昔单抗对激素依赖型肾病综合征患儿T淋巴细胞亚群和尿CD80水平的影响[J]. 东南大学学报(医学版), 2021, 40(5): 612-617.
[30] Gbadegesin, R.A., Adeyemo, A., Webb, N.J.A., Greenbaum, L.A., Abeyagunawardena, A., Thalgahagoda, S., et al. (2015) HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. Journal of the American Society of Nephrology, 26, 1701-1710. [Google Scholar] [CrossRef] [PubMed]
[31] Kimata, T., Tsuji, S., Kino, J., Kitao, T., Yamanouchi, S. and Kaneko, K. (2012) Close Association between Proteinuria and Regulatory T Cells in Patients with Idiopathic Nephrotic Syndrome. Pediatric Nephrology, 28, 667-669. [Google Scholar] [CrossRef] [PubMed]
[32] Bertelli, R., Bodria, M., Nobile, M., Alloisio, S., Barbieri, R., Montobbio, G., et al. (2011) Regulation of Innate Immunity by the Nucleotide Pathway in Children with Idiopathic Nephrotic Syndrome. Clinical and Experimental Immunology, 166, 55-63. [Google Scholar] [CrossRef] [PubMed]
[33] Tsuji, S., Kimata, T., Yamanouchi, S., Kitao, T., Kino, J., Suruda, C., et al. (2017) Regulatory T Cells and CTLA-4 in Idiopathic Nephrotic Syndrome. Pediatrics International, 59, 643-646. [Google Scholar] [CrossRef] [PubMed]
[34] Li, C., Gao, X., Ni, F., Liu, G. and Jia, S. (2023) Effects of the mTOR Pathway on the Balance of Th2/Treg Cells in Children with Idiopathic Nephrotic Syndrome. Indian Journal of Nephrology, 33, 93-100. [Google Scholar] [CrossRef] [PubMed]
[35] Li, Y.Y., Wei, S.G., Zhao, X., et al. (2016) Th17/Treg Cell Expression in Children with Primary Nephritic Syndrome and the Effects of Ox-LDL on Th17/Treg Cells. Genetics and Molecular Research, 15, 1-8. [Google Scholar] [CrossRef] [PubMed]
[36] Shao, X.S., Yang, X.Q., Zhao, X.D., Li, Q., Xie, Y.Y., Wang, X.G., et al. (2009) The Prevalence of Th17 Cells and FOXP3 Regulate T Cells (Treg) in Children with Primary Nephrotic Syndrome. Pediatric Nephrology, 24, 1683-1690. [Google Scholar] [CrossRef] [PubMed]
[37] Akilesh, S., Huber, T.B., Wu, H., Wang, G., Hartleben, B., Kopp, J.B., et al. (2008) Podocytes Use FcRn to Clear IgG from the Glomerular Basement Membrane. Proceedings of the National Academy of Sciences, 105, 967-972. [Google Scholar] [CrossRef] [PubMed]
[38] Reiser, J. and Mundel, P. (2004) Danger Signaling by Glomerular Podocytes Defines a Novel Function of Inducible B7-1 in the Pathogenesis of Nephrotic Syndrome. Journal of the American Society of Nephrology, 15, 2246-2248. [Google Scholar] [CrossRef] [PubMed]
[39] Garin, E.H., Diaz, L.N., Mu, W., Wasserfall, C., Araya, C., Segal, M., et al. (2009) Urinary CD80 Excretion Increases in Idiopathic Minimal-Change Disease. Journal of the American Society of Nephrology, 20, 260-266. [Google Scholar] [CrossRef] [PubMed]
[40] Fornoni, A., Sageshima, J., Wei, C., et al. (2011) Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis. Science Translational Medicine, 3, 85ra46. [Google Scholar] [CrossRef] [PubMed]
[41] Kaya, M., Girişgen, İ., Yalçın, N., Becerir, T., Şenol, H., Gülten, G., et al. (2023) The Importance of Sphingomyelin Phosphodiesterase Acid-Like 3b (SMPDL-3b) Levels in Kidney Biopsy Specimens of Children with Nephrotic Syndrome. Fetal and Pediatric Pathology, 42, 936-949. [Google Scholar] [CrossRef] [PubMed]
[42] Takahashi, Y., Ikezumi, Y. and Saitoh, A. (2016) Rituximab Protects Podocytes and Exerts Anti-Proteinuric Effects in Rat Adriamycin-Induced Nephropathy Independent of B-Lymphocytes. Nephrology, 22, 49-57. [Google Scholar] [CrossRef] [PubMed]
[43] Watanabe, S., Hirono, K., Aizawa, T., Tsugawa, K., Joh, K., Imaizumi, T., et al. (2020) Podocyte Sphingomyelin Phosphodiesterase Acid-Like 3b Decreases among Children with Idiopathic Nephrotic Syndrome. Clinical and Experimental Nephrology, 25, 44-51. [Google Scholar] [CrossRef] [PubMed]
[44] 李月兰. 他克莫司治疗儿童激素依赖型和耐药型肾病综合征的疗效比较[J]. 实用临床医药杂志, 2016, 20(7): 109-112.
[45] Ulinski, T. and Aoun, B. (2010) Pediatric Idiopathic Nephrotic Syndrome: Treatment Strategies in Steroid Dependent and Steroid Resistant Forms. Current Medicinal Chemistry, 17, 847-853. [Google Scholar] [CrossRef] [PubMed]
[46] Gellermann, J., Weber, L., Pape, L., Tönshoff, B., Hoyer, P. and Querfeld, U. (2013) Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome. Journal of the American Society of Nephrology, 24, 1689-1697. [Google Scholar] [CrossRef] [PubMed]
[47] Dorresteijn, E.M., Kist-van Holthe, J.E., Levtchenko, E.N., Nauta, J., Hop, W.C.J. and van der Heijden, A.J. (2008) Mycophenolate Mofetil versus Cyclosporine for Remission Maintenance in Nephrotic Syndrome. Pediatric Nephrology, 23, 2013-2020. [Google Scholar] [CrossRef] [PubMed]
[48] 许云鹏, 郭艳芳. 儿童难治性肾病综合征的治疗进展[J]. 中华临床医师杂志(电子版), 2014, 8(23): 4270-4273.
[49] Cammas, B., Harambat, J., Bertholet-Thomas, A., Bouissou, F., Morin, D., Guigonis, V., et al. (2010) Long-Term Effects of Cyclophosphamide Therapy in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome. Nephrology Dialysis Transplantation, 26, 178-184. [Google Scholar] [CrossRef] [PubMed]
[50] 余涛. 小儿激素依赖型肾病综合征应用长春新碱与环磷酰胺治疗的效果比较[J]. 河南医学研究, 2014, 23(10): 62-63.
[51] Couderc, A., Bérard, E., Guigonis, V., Vrillon, I., Hogan, J., Audard, V., et al. (2017) Traitements du syndrome néphrotique cortico-dépendant de l’enfant. Archives de Pédiatrie, 24, 1312-1320. [Google Scholar] [CrossRef] [PubMed]
[52] Iijima, K., Sako, M., Nozu, K., Mori, R., Tuchida, N., Kamei, K., et al. (2014) Rituximab for Childhood-Onset, Complicated, Frequently Relapsing Nephrotic Syndrome or Steroid-Dependent Nephrotic Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial. The Lancet, 384, 1273-1281. [Google Scholar] [CrossRef] [PubMed]
[53] Basu, B., Sander, A., Roy, B., Preussler, S., Barua, S., Mahapatra, T.K.S., et al. (2018) Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome. JAMA Pediatrics, 172, 757-764. [Google Scholar] [CrossRef] [PubMed]
[54] Bonanni, A., Rossi, R., Murtas, C., et al. (2015) Low-Dose Ofatumumab for Rituximab-Resistant Nephrotic Syndrome. BMJ Case Reports, 2015. [Google Scholar] [CrossRef] [PubMed]
[55] Wang, C., Liverman, R.S., Garro, R., George, R.P., Glumova, A., Karp, A., et al. (2017) Ofatumumab for the Treatment of Childhood Nephrotic Syndrome. Pediatric Nephrology, 32, 835-841. [Google Scholar] [CrossRef] [PubMed]
[56] Vivarelli, M., Colucci, M., Bonanni, A., Verzani, M., Serafinelli, J., Emma, F., et al. (2016) Ofatumumab in Two Pediatric Nephrotic Syndrome Patients Allergic to Rituximab. Pediatric Nephrology, 32, 181-184. [Google Scholar] [CrossRef] [PubMed]
[57] Dossier, C., Prim, B., Moreau, C., Kwon, T., Maisin, A., Nathanson, S., et al. (2020) A Global Antib Cell Strategy Combining Obinutuzumab and Daratumumab in Severe Pediatric Nephrotic Syndrome. Pediatric Nephrology, 36, 1175-1182. [Google Scholar] [CrossRef] [PubMed]
[58] Dossier, C., Bonneric, S., Baudouin, V., Kwon, T., Prim, B., Cambier, A., et al. (2023) Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children. Clinical Journal of the American Society of Nephrology, 18, 1555-1562. [Google Scholar] [CrossRef] [PubMed]

为你推荐